Technical analysis of Jaguar Health, Inc. (JAGX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health.
Price Performance
| 1 month | -76.15% |
| 3 months | -89.65% |
| Year-to-date | -99.29% |
| 1 year | -99.64% |
| 3 years | -100.00% |
| 5 years | -100.00% |
52-Week Range
| 52-week High | $85.40 |
| 52-week Low | $0.20 |
| Avg Volume (90d) | 249K |
Technical Indicators
| SMA 50 | $1.01 |
| SMA 200 | $14.13 |
| 30-day Volatility (annualised) | 171.2% |
| Price vs SMA 50 | -77.0% |
| Price vs SMA 200 | -98.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $67.90 | |
| 2025-11 | $47.25 | -30.4% |
| 2025-12 | $32.59 | -31.0% |
| 2026-01 | $23.61 | -27.6% |
| 2026-02 | $31.08 | +31.6% |
| 2026-03 | $12.97 | -58.3% |
| 2026-04 | $6.96 | -46.3% |
| 2026-05 | $3.55 | -49.0% |
| 2026-06 | $3.00 | -15.5% |
| 2026-07 | $1.00 | -66.7% |
| 2026-08 | $0.79 | -20.9% |
| 2026-09 | $0.23 | -70.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.23 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.03 |
| EV / EBITDA | -0.25 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 2.52 |
| Current Ratio | 0.69 |